← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exocell, Inc.
Philadelphia, PA
$5,014,815
Total funding
8
Grants
Funding over time
peak $1.1M · FY2005–07$2M$1.5M$1M$500K$0
'05
'06
'07
Funding mix
By agency
NIH$5,014,815 · 8
By mechanism
R44$4,608,506 · 4
R43$406,309 · 4
Investigators at Exocell, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
LDL Modification in Diabetic Complications$1,129,672
R44 · FY2007 · DK
LDL Modification in Diabetic Complications$641,272
R44 · FY2006 · DK
Reducing Renal TGF-B in Diabetic Glomerulosclerosis$636,114
R44 · FY2003 · DK
Reducing Renal TGF-B in Diabetic Glomerulosclerosis$600,752
R44 · FY2004 · DK
Point-of-Care Measurement of Glycated Hemoglobin$429,904
R44 · FY2003 · DK
NOVEL AGENTS TO PREVENT KIDNEY DISEASE IN DIABETES$369,099
R44 · FY2000 · DK
Point-of-Care Measurement of Glycated Hemoglobin$287,693
R44 · FY2004 · DK
Reducing Renal TGF-B in Diabetic Glomerulosclerosis$264,000
R44 · FY2005 · DK
Reducing Renal TGF-B in Diabetic Glomerulosclerosis$250,000
R44 · FY2004 · DK
LDL Modification and Diabetic Renal Dysfunction$104,298
R43 · FY2005 · DK
Urinary Collagen IV in Diabetic Glomerulosclerosis$102,051
R43 · FY2003 · DK
Point-of-Care Measurement of Glycated Hemoglobin$100,000
R43 · FY2002 · DK
Reducing Renal TGF-B in Diabetic Glomerulosclerosis$99,960
R43 · FY2002 · DK